BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35179971)

  • 1. Prostate MRI quality: clinical impact of the PI-QUAL score in prostate cancer diagnostic work-up.
    Karanasios E; Caglic I; Zawaideh JP; Barrett T
    Br J Radiol; 2022 May; 95(1133):20211372. PubMed ID: 35179971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of PI-QUAL on PI-RADS and cancer yield in an MRI-TRUS fusion biopsy population.
    Pötsch N; Rainer E; Clauser P; Vatteroni G; Hübner N; Korn S; Shariat SF; Helbich TH; Baltzer PAT
    Eur J Radiol; 2022 Sep; 154():110431. PubMed ID: 35803101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial.
    Giganti F; Dinneen E; Kasivisvanathan V; Haider A; Freeman A; Kirkham A; Punwani S; Emberton M; Shaw G; Moore CM; Allen C
    Eur Radiol; 2022 Feb; 32(2):879-889. PubMed ID: 34327583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assessment of prostate MRI by PI-QUAL score: Inter-reader agreement and impact on prostate cancer local staging at 3 Tesla.
    Coelho FMA; Amaral LTW; Mitsutake LKN; Mussi TC; Baroni RH
    Eur J Radiol; 2023 Aug; 165():110921. PubMed ID: 37336037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter-reader agreement of the Prostate Imaging Quality (PI-QUAL) score: A bicentric study.
    Girometti R; Blandino A; Zichichi C; Cicero G; Cereser L; De Martino M; Isola M; Zuiani C; Ficarra V; Valotto C; Bertolotto M; Giannarini G
    Eur J Radiol; 2022 May; 150():110267. PubMed ID: 35325773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-reader agreement of the prostate imaging quality (PI-QUAL) score for basic readers in prostate MRI: A multi-center study.
    Basar Y; Alis D; Seker ME; Kartal MS; Guroz B; Arslan A; Sirolu S; Kurtcan S; Denizoglu N; Karaarslan E
    Eur J Radiol; 2023 Aug; 165():110923. PubMed ID: 37320883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bridging the experience gap in prostate multiparametric magnetic resonance imaging using artificial intelligence: A prospective multi-reader comparison study on inter-reader agreement in PI-RADS v2.1, image quality and reporting time between novice and expert readers.
    Forookhi A; Laschena L; Pecoraro M; Borrelli A; Massaro M; Dehghanpour A; Cipollari S; Catalano C; Panebianco V
    Eur J Radiol; 2023 Apr; 161():110749. PubMed ID: 36812699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-reader variability and reproducibility of the PI-QUAL score in a multicentre setting.
    Fleming H; Dias AB; Talbot N; Li X; Corr K; Haider MA; Ghai S
    Eur J Radiol; 2023 Nov; 168():111091. PubMed ID: 37717419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy.
    Brembilla G; Lavalle S; Parry T; Cosenza M; Russo T; Mazzone E; Pellegrino F; Stabile A; Gandaglia G; Briganti A; Montorsi F; Esposito A; De Cobelli F
    Eur J Radiol; 2023 Jul; 164():110849. PubMed ID: 37141845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-reader evaluation of different image quality scoring systems in prostate MRI.
    Hötker AM; Njoh S; Hofer LJ; Held U; Rupp NJ; Ghafoor S; Stocker D; Eberli D; Donati OF
    Eur J Radiol; 2023 Apr; 161():110733. PubMed ID: 36780738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoting the use of the PI-QUAL score for prostate MRI quality: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship.
    Giganti F; Cole AP; Fennessy FM; Clinton T; Moreira PLDF; Bernardes MC; Westin CF; Krishnaswamy D; Fedorov A; Wollin DA; Langbein B; Frego N; Labban M; Badaoui JS; Chang SL; Briggs LG; Tokuda J; Ambrosi A; Kirkham A; Emberton M; Kasivisvanathan V; Moore CM; Allen C; Tempany CM
    Eur Radiol; 2023 Jan; 33(1):461-471. PubMed ID: 35771247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard.
    Schimmöller L; Quentin M; Arsov C; Lanzman RS; Hiester A; Rabenalt R; Antoch G; Albers P; Blondin D
    Eur Radiol; 2013 Nov; 23(11):3185-90. PubMed ID: 23756958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of non-endorectal prostate MR image quality using PI-QUAL: A multidisciplinary team approach.
    Robertson SH; Owenby E; Beasley C; Wall L; Gray B; Boru I; Kalisz KR; Kruse DE; Marin D; Thomas SP; Macdonald EB; Purysko AS; Gupta RT
    Eur J Radiol; 2023 Sep; 166():110998. PubMed ID: 37506475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate MR image quality of apparent diffusion coefficient maps versus fractional intracellular volume maps from VERDICT MRI using the PI-QUAL score and a dedicated Likert scale for artefacts.
    Singh S; Giganti F; Dickinson L; Rogers H; Kanber B; Clemente J; Pye H; Heavey S; Stopka-Farooqui U; Johnston EW; Moore CM; Freeman A; Whitaker HC; Alexander DC; Panagiotaki E; Punwani S
    Eur J Radiol; 2023 Nov; 168():111109. PubMed ID: 37769532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION trial.
    Giganti F; Allen C; Emberton M; Moore CM; Kasivisvanathan V;
    Eur Urol Oncol; 2020 Oct; 3(5):615-619. PubMed ID: 32646850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taking PI-QUAL beyond the prostate: Towards a standardized radiological image quality score (RI-QUAL).
    Becker AS; Giganti F; Purysko AS; Fainberg J; Vargas HA; Woo S
    Eur J Radiol; 2023 Aug; 165():110955. PubMed ID: 37421773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for prostate cancer in men with false-negative mpMRI: A retrospective single center cohort study of image quality scores and clinical parameters.
    Pausch AM; Ghafoor S; Kluckert J; Rupp NJ; Eberli D; Hötker AM
    Eur J Radiol; 2024 Jan; 170():111227. PubMed ID: 38039782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the PI-RADS 2.1 scoring system to PI-RADS 2.0: Impact on diagnostic accuracy and inter-reader agreement.
    Hötker AM; Blüthgen C; Rupp NJ; Schneider AF; Eberli D; Donati OF
    PLoS One; 2020; 15(10):e0239975. PubMed ID: 33017413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a dedicated PI-QUAL curriculum on the assessment of prostate MRI quality.
    Wang R; Pinto D; Liu T; Hamade M; Jubane M; Arif A; Boateng J; Maloney S; Amin A; Sandhu J; Nini S; Manov J; Tordjman L; Villavicencio J; Chamoun M; Leslom S; Aristizabal J; Felix M; Gomez-Rodriguez C; Alessandrino F
    Eur J Radiol; 2023 Jul; 164():110865. PubMed ID: 37167684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Prostate Cancer in PI-RADS Version 2.1 Transition Zone Atypical Nodules Upgraded by Abnormal DWI: Correlation With MRI-Directed TRUS-Guided Targeted Biopsy.
    Lim CS; Abreu-Gomez J; Carrion I; Schieda N
    AJR Am J Roentgenol; 2021 Mar; 216(3):683-690. PubMed ID: 32755208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.